WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement on the announcement by congressional leadership of a funding agreement that includes full repeal of the medical device excise tax. The agreement is expected to be passed this week by Congress and signed into law by President Trump:
Download Artificial intelligence (AI) applied to healthcare, driven by innovative medical technology, has and will continue to transform patient care.
Outlining the facts and dispelling myths will inform policymaking to avoid overlap with current regulations and preserve the broad capacity of innovation to help patients.
Join Deloitte and AdvaMed for an insightful webinar on redefining the medtech industry through ‘connected care.’
Join Deloitte and AdvaMed for an insightful webinar on redefining the medtech industry through ‘connected care.’
The MedTech Conference has grown into the industry’s premier annual event worldwide. Every year, attendees come away with unmatched insights, connections, and enthusiasm for their…
Today, AdvaMed, the MedTech Association, released the findings of a new national poll on radiation therapy and cancer treatment revealing broad support for greater federal…
Kimberly Bari “I felt like I was losing my mind.” At 26, Kimberly Bari was experiencing seizures on a daily basis. Prescribing everything from anti-epileptic…
The AdvaMed PRIDE Leadership Network seeks to build community, enhance visibility, and elevate professionals in the LGBTQ community.
This Women’s Health Month, AdvaMed is highlighting new developments in breast cancer screening. The U.S. Preventive Services Task Force (Task Force)
“Here at J&J MedTech, the AdvaMed Code of Ethics serves as a valuable resource for interactions with healthcare professionals and stakeholders. The
